Nuveen Multi Cap Value Fund Class A
NQVAX
NASDAQ
| Weiss Ratings | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C+ | |||
| Risk Index | Good | |||
| Risk Grade | B | |||
| Company Info | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Nuveen | |||
| Manager/Tenure (Years) | Jon D. Bosse (28), James T. Stephenson (0) | |||
| Website | http://www.nuveen.com | |||
| Fund Information | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Nuveen Multi Cap Value Fund Class A | |||
| Category | Mid-Cap Value | |||
| Sub-Category | US Equity Large Cap Value | |||
| Prospectus Objective | Growth | |||
| Inception Date | Dec 09, 2002 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 2,500.00 | |||
| Minimum Subsequent Investment | 100.00 | |||
| Front End Fee | 0.06 | |||
| Back End Fee | -- | |||
| Dividends and Shares | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.20% | |||
| Dividend | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 2.08% | |||
| Asset Allocation | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 2.83% | |||
| Stock | 97.17% | |||
| U.S. Stock | 86.37% | |||
| Non-U.S. Stock | 10.80% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.64% | |||
| 30-Day Total Return | -1.84% | |||
| 60-Day Total Return | -0.39% | |||
| 90-Day Total Return | 2.91% | |||
| Year to Date Total Return | 4.06% | |||
| 1-Year Total Return | 28.56% | |||
| 2-Year Total Return | 35.90% | |||
| 3-Year Total Return | 62.06% | |||
| 5-Year Total Return | 77.56% | |||
| Price | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $65.56 | |||
| 1-Month Low NAV | $63.35 | |||
| 1-Month High NAV | $67.16 | |||
| 52-Week Low NAV | $47.36 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $68.42 | |||
| 52-Week High Price (Date) | Feb 11, 2026 | |||
| Beta / Standard Deviation | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.82 | |||
| Standard Deviation | 11.84 | |||
| Balance Sheet | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 1.08B | |||
| Operating Ratios | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.15% | |||
| Turnover Ratio | 30.00% | |||
| Performance | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 20.77% | |||
| Last Bear Market Total Return | -13.52% | |||